Invivo Therapeutics Holdings Corp. financial data

Industry
Surgical & Medical Instruments & Apparatus
Location
One Kendall Square, Building 1400 East 4 Th Floor, Cambridge, MA
State of incorporation
NV
Fiscal year end
December 31
Former names
Design Source, Inc. (to 10/5/2010)
Latest financial report
10-Q - Q3 2023 - Nov 8, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 889 % +41.5%
Debt-to-equity 15.4 % -33.8%
Return On Equity -75 % +3.93%
Return On Assets -65 % -2.65%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.11M shares +62.2%
Common Stock, Shares, Outstanding 3.11M shares +123%
Entity Public Float 5.63M USD -77.8%
Common Stock, Value, Issued 3K USD 0%
Weighted Average Number of Shares Outstanding, Basic 3.11M shares +123%
Weighted Average Number of Shares Outstanding, Diluted 3.11M shares +123%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 4.08M USD -22.7%
General and Administrative Expense 5.78M USD -0.99%
Operating Income (Loss) -9.86M USD +11.3%
Nonoperating Income (Expense) 529K USD +690%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -9.33M USD +15.5%
Earnings Per Share, Basic -3.28 USD/shares +59.1%
Earnings Per Share, Diluted -5.74 USD/shares +23.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 8.58M USD -19%
Other Assets, Current 321K USD -53.2%
Assets, Current 9.53M USD -17.6%
Property, Plant and Equipment, Net 9K USD -96.1%
Operating Lease, Right-of-Use Asset 643K USD -38.1%
Assets 9.58M USD -28.2%
Accounts Payable, Current 123K USD -85.8%
Accrued Liabilities, Current 543K USD -56.6%
Liabilities, Current 666K USD -73.4%
Operating Lease, Liability, Noncurrent 280K USD -62.9%
Other Liabilities, Noncurrent 109K USD +14.7%
Liabilities 666K USD -79.6%
Retained Earnings (Accumulated Deficit) -256M USD -3.79%
Stockholders' Equity Attributable to Parent 8.92M USD -11.7%
Liabilities and Equity 9.58M USD -28.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.2M USD +16.3%
Net Cash Provided by (Used in) Investing Activities 2K USD
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 3.11M shares +123%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.2M USD +16.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 8.63M USD -19.7%
Deferred Tax Assets, Valuation Allowance 47.5M USD +6.07%
Deferred Tax Assets, Gross 47.5M USD +6.07%
Operating Lease, Liability 754K USD -33.5%
Depreciation 53K USD +8.16%
Payments to Acquire Property, Plant, and Equipment 21K USD -19.2%
Lessee, Operating Lease, Liability, to be Paid 0 USD -100%
Property, Plant and Equipment, Gross 15K USD -98.2%
Operating Lease, Liability, Current 474K USD +25.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 568K USD +29.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 568K USD +29.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 34K USD -62.2%
Deferred Tax Assets, Operating Loss Carryforwards 44.2M USD +3.64%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Operating Lease, Payments 400K USD -5.88%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 19K USD +46.2%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 187K USD -3.11%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%